Biotransformation of Silver Released from Nanoparticle Coated Titanium Implants Revealed in Regenerating Bone by Geng, Hua et al.
Accepted for publication in ACS Applied Materials & Interfaces, 05/06/17 
 1 
Biotransformation of Silver Released from 
Nanoparticle Coated Titanium Implants Revealed in 
Regenerating Bone 
Hua Geng1,2, Gowsihan Poologasundarampillai1,2, Naomi Todd3, Aine Devlin-Mullin3, Katie 
Moore1, Zahra Golrokhi4, James B. Gilchrist2, Eric Jones4, Richard J. Potter4, Chris Sutcliffe4, 
Marie O'Brien1, David. W.L. Hukins5, Sarah Cartmell1, Christopher A. Mitchell3, Peter D. Lee1,2* 
1School of Materials, The University of Manchester, Oxford Road, M13 9PL, UK 
2Research Complex at Harwell, OX11 0FA, Harwell, UK 
3Centre for Molecular Biosciences (CMB), School of Biomedical Sciences, Ulster University, 
Coleraine, Northern Ireland 
4Centre for Materials and Structures, School of Engineering, the University of Liverpool, 
Liverpool L69 3GH, UK 
5Department of Mechanical Engineering, School of Engineering, University of Birmingham, 
Birmingham, UK 
*Corresponding author: Professor Peter D. Lee peter.lee@manchester.ac.uk 
 
KEYWORDS: Silver nanoparticle coatings; atomic layer deposition; biotransformation; bone 
formation; osseointegration 
 
Accepted for publication in ACS Applied Materials & Interfaces, 05/06/17 
 2 
ABSTRACT 
 
Antimicrobial silver nanoparticle coatings have attracted interest for reducing prosthetic joint 
infection. However, few studies report in vivo investigations of the biotransformation of silver 
nanoparticles within the regenerating tissue and its impact on bone formation. We present a 
longitudinal investigation of the osseointegration of silver nanoparticle-coated additive 
manufactured titanium implants in rat tibial defects. Correlative imaging at different time points, 
using nanoscale secondary ion mass spectrometry, transmission electron microscopy (TEM), 
histomorphometry and 3D X-ray micro-computed tomography, provided quantitative insight 
from the nano to macro scales. The quality and quantity of newly formed bone is comparable 
between the uncoated and silver coated implants. The newly formed bone demonstrates a 
trabecula morphology with bone being located at the implant surface as well as at a distance at 2 
weeks. Nanoscale elemental mapping of the bone-implant interface showed that silver was 
present primarily in the osseous tissue and was co-localized with sulfur. TEM revealed silver 
sulfide nano-particles in the newly regenerated bone, presenting strong evidence that the 
previously in vitro observed biotransformation of silver to silver sulfide occurs in vivo. 
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1. INTRODUCTION 
 
Additive manufactured (AM) open-porous titanium implants 1-2 are increasingly used in 
orthopaedic applications where bone fixation and load bearing are required. These open-porous 
implants allow desirable early bone ingrowth 3 and more rapid osseointegration 4-5. 
Unfortunately, the placement of prostheses is also associated with the risk of prosthetic joint 
infection (PJI) 6-7, ultimately leading to delayed healing or implant failure. It has been estimated 
that 2.5 % of patients with primary knee and up to 20% of revision knee replacement has been 
affected by PJI 8-9. Treatment of such infection with antibiotics proves to be ineffective due to 
biofilm formation, with the ability of the immune system to respond also being hampered 10-11. 
Therefore, an antimicrobial surface aimed at preventing the bacterial colonisation and biofilm 
formation during surgery and in the immediate postoperative period is highly desirable. 
Silver based antimicrobials are of particular interest due to their broad antimicrobial 
spectrum and efficacy 12-13, allowing them to inhibit both gram-positive and gram-negative 
bacteria with very low silver concentrations. Nanoscale silver (nano-Ag) such as silver 
nanoparticles (AgNPs) is more reactive than its bulk counterparts due to the large surface area-
to-volume ratio 14. The interaction of AgNPs with moisture and body fluid leads to the fast 
release of biologically active silver ions 15, binding to bacterial protein or DNA 16, thereby 
preventing bacterial adhesion and biofilm formation. In addition, ultra-thin AgNP films have 
been successfully incorporated onto non-planar surfaces and complex architectures by several 
techniques 17-19. Atomic layer deposition (ALD), a sequential and self limiting process, provides a 
number of advantages for depositing an AgNP surface layer, including texturing and 
biocompatibility. The sub angstrom control of silver precursor deposition, coupled with the self 
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saturating reaction lead to the formation of uniform sized AgNPs coated onto the additive 
manufactured porous titanium 17. In a previous study, ALD of a silver coated Ti implants was 
shown to be effective in reducing major pathogenic biofilm formation in vitro 20. 
The remarkable antimicrobial effects of AgNPs have led to their application in a diverse 
range of orthopaedic implants. However, the close contact that exists between silver coated 
implants and bone 21 also raises concerns regarding the potentially harmful effect associated with 
the uptake of the silver ions into bone and surrounding soft tissue 22. AgNPs can readily penetrate 
the cell membrane 23, releasing ions locally to a specific tissue 24 and becoming internalized 25-26. 
Therefore, a detailed study on the impact of AgNPs is required. 
Considerable effort has been expended in examining the biological effect of silver on 
bone using a variety of cell lines, and it has been shown that the impact of AgNPs is both size- 27-
28 and dose-dependent 29-33. These in vitro studies provide an understanding of silver interaction 
with the specific cell types involved in bone healing, revealing a potential reduction in possible 
harmful effects by controlling the initial total amount of silver. Further, recent in vitro evidence 
suggests that the silver undergoes sulfidation to silver sulfide 34 through complex interactions 
with protein (serum) and cells 35. This lead to the hypothesis that the biological toxicity of silver 
is reduced through the biotransformation of sliver into silver sulfide, a more stable and less toxic 
compound 35. However, the cellular response triggered by silver, and its sulfidation to silver 
sulfide in vitro, cannot be directly used to predict tissue level response in vivo. Bone healing, 
when augmented by implants, is characterized by complex interactions between multiple cell 
types and the osteoconductive properties of the material 36-39, all of which could be disrupted by 
silver. 
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In the majority of prior studies, there is a lack of information dealing with the harmful 
effects of silver on bone regeneration, with apparent inconsistencies in the results obtained. 
Korani et al. 40 observed an abnormal inflammatory response in lamellar bone following the 
dermal exposure of silver. On the contrary, Marsich et al. 41 found comparable bone healing 
patterns without significant difference in bone contact. These contradictory results may be 
explained by the differences in routes of exposure (e.g. bone contact, blood contact or inhalation) 
and experiment end-point, inevitably raising doubts about whether silver coating is detrimental 
to bone healing. 
To date, only a few studies have focused on the effect of silver on bone regeneration 
associated with implanted materials 41-42. However, none have performed investigations 
examining multiple time-points during incorporation of implants nor have they assessed the 
uptake/distribution of silver in tissue upon release from an implant. These aforementioned 
experiments can provide particularly useful information regarding the possible biological effect 
of silver on bone healing and potential target tissue following the contact of new bone and silver 
coated devices, respectively. For these reasons, detailed in vivo studies are required to fully 
elucidate the impact of silver on bone healing. 
In the present study, the quantity and quality of bone following surgical implantation of 
both silver coated and uncoated titanium scaffolds were assessed using both X-ray micro-
computed tomography (µCT) and histological measurements. The impact of silver coating was 
assessed after 2, 6 and 12 weeks in vivo, to identify whether the presence of silver affects bone 
healing or decreases new bone generation. The distributions of released silver (107Ag-) in addition 
to 12C-, 40Ca16O- 31P12C-, 32S- within adjacent tissues were quantified using nanoscale secondary 
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ion mass spectrometry (NanoSIMS). Transmission electron microscopy (TEM) and selected area 
electron diffraction (SAED) were combined to examine the newly formed bone. Correlative 
imaging was used combine all of these complementary techniques to investigate the bone-
implant interface and the biotransformation of the silver. 
2. MATERIALS AND METHODS 
2.1 Fabrication and preparation of the open-porous implants 
Open-porous titanium implants were fabricated by additive manufacturing as previously 
described 43. Briefly, cylindrical shaped titanium implants of 2.5 mm diameter and 1.5 mm 
height, as shown in Fig. 1a, were produced using a MCP Realizer 250 Selective Laser Melting 
(SLM) system (MCP Tooling Technologies, Lubeck, Germany). The basic material used to 
fabricate implants was Grade 1 commercially pure titanium (CP-Ti) powder with a modal 
particle diameter of 28.5 µm (Sumitomo Corp., Tokyo, Japan) 43. The powder layer thickness 
used in the build process was 50 µm 43. The open-porous implants were made with a nominal 
porosity of 65 % and a strut diameter of 180 µm 2. 
Following the SLM build process, the implants were cleaned in an ultrasonic bath (VWR, 
Radnor, USA) with micro-90 detergent (Decon, Sussex, UK) diluted 1:20 in distilled water to 
remove un-fused powder. The samples were then rinsed in distilled water and dried. Once 
cleaned, the samples were subject to heat treatment in an inert atmosphere at 667 Pa and 1400°C 
(for 3 hours). Before atomic layer deposition, the sintered implants were once again sintered and 
cleaned using the process described above. 
2.2 Atomic layer deposition (ALD) of the AgNPs coating 
Accepted for publication in ACS Applied Materials & Interfaces, 05/06/17 
 7 
Surface modification of the implant samples with an ultra-thin layer of silver was carried 
out using direct liquid injection atomic layer deposition (ALD) in a customized Aixtron AIX 
200FE AVD reactor [20]. The ALD process used has been shown to be controlled by self-
limiting surface reactions, enabling the production of highly conformal nano-textured metallic 
silver films on complex three-dimensional structures 44. The organometallic precursor and co-
reactant used in the deposition process was (hexafluoroacetylacetonato)silver(I)(1,5-
cyclooctadiene) dissolved in a 0.1 M anhydrous toluene solution (Sigma-Aldrich, Germany) and 
propan-1-ol (HPLC grade/Fisher, Leics, UK), respectively. Each ALD cycle consisted of a four 
step process, starting with a 4 s dose of the silver precursors, followed by an 8 s argon (99.999%; 
BOC, UK) purge, and then a 4 s propan-1-ol dose and finally another 8 s argon purge. The silver 
precursor solution was introduced into the reactor using direct liquid injection at a rate of 17.5 
μl/s and was volatilized at 130°C, while the propan-1-ol was delivered into the reactor from a 
vapor-draw bottle held at room temperature (~20°C) using a Swagelok ALD valve. Each sample 
was coated using 500 ALD cycles to give a nominal film thickness (if uniform rather than 
particulate islands) of ~13 nm which corresponds to a rate of 0.026 nm/cycle.  
2.3 Scanning Electron Microscopy 
The structure of the Ti and Ti-Ag implants was characterised by scanning electron 
microscopy (JEOL JSM-7001F FEG-SEM, Tokyo, Japan) in secondary electron mode, using a 
10 kV accelerating voltage.  
2.4 Sterilization  
Before implantation, all samples were soaked in ethanol for 2 hours before sterilization 
with ultraviolet (UV) light in a Class II biosafety cabinet (Esco, Canada) 45. 
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2.5 Surgical implantation 
A total of thirty-six adult male Wistar rats, 10–12 weeks old and weighting 300–400 g, 
were used for the in vivo study. The experimental protocol was approved by the institutional 
animal care committee at the University of Ulster and National (UK Home Office) guidelines. In 
brief, an anesthetic drug (2.0 ml Ketaset, 100 ml/mg) and 1.0 ml Xylapan (20 ml/mg) diluted in 5 
ml phosphate buffered saline (PBS) (pH 7.4, 0.5 ml/100 g) was injected to sedate the animals. 
For the surgical procedures, a 2.5 mm subcritical size defect was created using a trephine bur. 
The circular defect penetrated well into the marrow cavity. Rats were randomly divided into two 
groups of eighteen rats each, implanted with titanium (Ti) or silver coated titanium implants (Ti-
Ag).  
After healing period of 2, 6 and 12 weeks, the animals were sacrificed and the implanted 
tibiae were subsequently fixed in a solution of 10% buffered formal saline for X-ray micro-
computed tomography (μCT) scanning. 
2.6 Ex-vivo X-ray micro-computed tomography (µCT) 
2.6.1. Image acquisition 
Post-implantation, all implanted tibiae (n = 36) were wrapped in Parafilm M (Bemis, US) 
and placed in an ABS plastic tube. The scanning was performed by using a laboratory based µCT 
system (Nano-focus, Phoenix|x-ray General Electric Company, Measurement and Control, 
Wunstorf, Germany). In order to reduce beam hardening artefacts [37], the µCT scanner was 
operated at 85 kV and 111 µA with a 0.5 mm thick copper filter. Images were reconstructed 
using the Datos|x software (Phoenix|x-ray) resulting in an image matrix of 990 × 990 × 1000 
pixels with an isotropic voxel size of 5 μm. The reconstructed images were subsequently 
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analyzed in Avizo software (Avizo 8.0, FEI Visualization Sciences Group, Mérignac Cedex, 
France) and Matlab (Mathworks Inc., Natick, Massachusetts, USA).  
2.6.2. Segmentation 
The segmentation procedure comprised an image filter, a global threshold and a local 
thresholding method 46. In the first pass, the reconstructed data were normalized to a pre-
determined reference histogram before undergoing smoothing filters (edge preserving filter and 
anisotropic diffusion filter) 47, to reduce the influence of noise and artefacts. The filtered images 
were first pre-segmented into a ‘mask’ containing bone and implant areas using an Ostu 
algorithm 46. After pre-segmentation, the bone was segmented from the implant area using local 
thresholding 46. The boundary between the bone and implant was smoothed using the 
morphological operations of erosion (by one pixel) and dilation (by one pixel). 
2.6.3. Quantification of the titanium scaffold and newly formed bone 
After segmentation, the bone and titanium phases from each individual sample were 
registered with a high resolution tibia shape model and a cylindrical mask (2.5 mm in diameter 
and 1.5 mm in height), respectively. The overlapping of the shape model and cylindrical mask 
were used to generate the region of interest (ROI) in a reproducible fashion (Fig.2a). Micro-
architectural parameters (1) bone ingrowth (BI) [(bone area/ROI) × 100%], (2) bone contact 
(BC) [(bone contact area/ (total scaffold area) × 100%), (3) specific surface area (SSA) [(bone 
area/bone volume) × 100%], (4) bone trabecular thickness (Tb.Th), and (5) trabecular separation 
(Tb.Sp) 48 of the newly formed bone were analysed within the defined ROI. Strut thickness and 
porosity of the titanium scaffolds were measured 2, 49. 
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2.7 Histology and histomorphometry 
Histological preparation of rat tibiae containing titanium implants has been previously 
described in detail 50. Briefly, eighteen tibial specimens containing the implants (n = 3 at 2, 6 and 
12 weeks in the Ti and Ti-Ag groups) were decalcified, dehydrated, infiltrated and embedded in 
LR white resin (TAAB Laboratories Equipment Ltd, Berks, UK). The polymerized blocks were 
trimmed of excess resin and glued onto plastic microscope slides (EXAKT, Oklahoma City, 
USA). An EXAKT Vacuum Adhesive Press was used to mount the samples for UV treatment (5 
minutes). Subsequently, one half of the samples were cut approximately from the centre of the Ti 
implant using an EXAKT 310 Macro Band System with a diamond blade (EXAKT, Oklahoma 
City, USA). The blocks were ground successively with K800, K2500, and K4000 grinding paper 
(EXAKT) using an EXAKT 400CS grinding system to yield ~50 -100 µm thick sections. 
Finally, the sections were stained with Gill’s Haematoxylin III (Fisher Scientific, Loughborough, 
UK) and multiple staining solution before examination on a Zeiss Axiophot microscope (Zeiss; 
Wetzlar, Germany). Histomorphometric analysis of new bone consisted of a quantitative 
assessment of the bone ingrowth (BI). 
2.8 Sample preparation for spectroscopic analyses  
Four non-decalcified samples of tibia with implant (n = 1 at 2 weeks in the Ti group; n = 
1 at 2, 6 and 12 weeks in the Ti-Ag group) were washed in distilled water and kept in a −80°C 
freezer (New Brunswick Scientific, Enfield, USA) for 48 h. The frozen samples were then freeze 
dried in a CoolSafe 100-4 freeze-drier (Scanvac-Coolsafe, Lynge, UK) for 48 hours. At the end 
of the drying cycle, bone-implant samples were mounted in LR White resin (Sigma-Aldrich, 
Dorset, UK) and polished to a mirror finish using 1 micron diamond suspension paste (Struers, 
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Glasgow, UK). Immediately before NanoSIMS analysis the embedded samples were coated with 
10 nm of platinum. 
2.9 NanoSIMS 
NanoSIMS images of the bone implant samples were acquired using a CAMECA 
NanoSIMS 50L instrument (Cameca, Gennevilliers Cedex, France). A 16 keV Cs+ primary ion 
beam with a current of 1.8 – 2.6 pA was scanned over the surface to generate negative secondary 
ions. The instrument was calibrated, using standards of high concentration, to detect 12C-, 32S-, 
31P12C-, 40Ca16O-, 48Ti16O- and 107Ag-. In order to ensure that each imaged area was at steady state 
and to remove the platinum coating, Cs+ ions were implanted into the surface to achieve a dose 
of 1 x 1017 ions cm-2. Six to eight regions of interest were imaged from each sample with an area 
of 50 × 50 μm2 (512 × 512 pixels). A dwell time of 5000 μs/pixel was used with an aperture size 
of 300 μm (D1 = 2). Image processing was carried out using ImageJ software (U.S. National 
Institutes of Health, Bethesda, Maryland, USA) with OpenMIMS plugin (National Resource for 
Imaging Mass Spectrometry, Cambridge, Massachusetts, USA).  
2.10 Sample preparation for correlative imaging  
After the NanoSIMS experiments, the surface that was analyzed with NanoSIMS was 
polished using a 6 µm diamond suspension (Struers, Glasgow, UK) and glued onto a glass slide 
(Thermo Scientific, Hudson, USA). The other side of sample was further ground using K1200 
and P4000 grinding paper (Struers, Glasgow, UK) until the sample was 70-90 μm thick. These 
sections were stained with Goldners Trichrome (method adapted from 51). Briefly, the sections 
were rinsed with distilled water for 15 mins and the nuclei stained for 20 mins using Weigert’s 
Haematoxylin (Sigma-Aldrich, Dorset, UK). The sections were then rinsed with distilled water 
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and stained with 0.01% Azophloxine for 15 mins. Sections were then rinsed with 1% acetic acid 
followed by staining with 2% Orange G for 3 mins and rinsed again with 1% acetic acid. Lastly, 
they were stained with 0.2% Light Green for 5 mins followed again by rinsing with 1% acetic 
acid for 5 mins. The sections were then blotted dry and imaged using Olympus SZX16 
stereoscopic microscope at a range of magnifications. The histological appearance of tissues in 
the images is consistent, with mineralized bone staining green/dark green and fibrous tissue as 
orange/orange red.  
2.11 TEM imaging 
The Goldners Trichrome stained histological sections were polished to ~30 µm using 
P4000 grinding paper (Struers, Glasgow, UK). The section was then mounted in a 3.05 mm Cu 
folding grid with a 1 mm circular hole in the center (Agar Scientific, UK). To thin the section to 
electron transparency a Fischione 1050 Ar+ mill was used. Thinning was performed at 
successively lower beam energies and shallower angles (with respect to the section plane). Initial 
beam conditions were 10 kV and ±10º. Final thinning conditions were 4 kV and ±6º. 
To differentiate the bone and fibrous tissue, the ion beam milled bone implant sample 
was imaged using a stereoscopic microscope (Olympus SZX16) at a range of magnifications. 
The sample was then imaged using a JEOL 2100 TEM operated at 200 kV. Images and 
diffraction patterns were acquired up to ~5 µm from the implant surface. For imaging, a 1 s 
camera exposure time was used. For diffraction patterns a ~0.4 μm SA aperture and a 5 s camera 
exposure time were used. 
2.12 Statistical Analyses  
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The results from µCT (n = 6) and histomorphometry analysis (n = 3) are presented as 
mean ± standard deviation. Statistical comparisons were performed with a Mann–Whitney U 
test. All statistical analysis was carried out using XLSTAT (Addinsoft, Inc., USA), with 
statistical significance considered when p < 0.05(*).  
3. RESULTS 
3.1 Characterization of the open-porous titanium implants  
The Ti implants (Fig.1a) were found to have a porosity of 67 ± 5% and the modal strut 
diameter was 170 ± 20 µm. This compares favorably with the original design, which aimed to 
have 65% porosity and 180 µm struts 2. The selective laser melting (SLM) of the pure Ti 
powders gives rise to scaffolds (Fig. 1b) with a rough surface, irregular shape and a large surface 
area. During the ALD deposition process, metallic AgNPs (Fig. 1c) are uniformly deposited on 
the porous Ti surface. From the size distribution histogram (Fig. 1d), an average particle size of 
49 ± 3 nm could be estimated. 
3.2 Analysis of quantity of bone using Ex vivo x-ray micro-computed tomography  
3.2.1. Bone Ingrowth (BI) 
Three-dimensional µCT analysis of the entire implant was performed on 2, 6, and 12 
week samples of rat tibia containing titanium scaffolds to assess bone ingrowth in a pre-defined 
ROI (Fig. 2a). Representative µCT images (Fig. 2b-2g) qualitatively confirm bone formation 
progresses over time for both the uncoated and silver coated titanium scaffolds. New bone was 
observed at the edge and interior of the defect site at two weeks after implantation, with 35 ± 
10% and 31 ± 5% of void space being replaced by irregular immature bone (Fig. 2b, 2c). At six 
weeks post-implantation, a higher proportion of new bone was detected along the porous 
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titanium implant from the surface to the center (Fig. 2d, 2e). After twelve weeks, the implant 
pores were almost completely filled by newly formed bone (Fig. 2f, 2g). The results of the 
quantitative data measured from µCT are summarized in Table 1 and Fig. 2h. No difference in 
bone ingrowth was observed between the Ti and Ti-Ag groups. There were significant statistical 
differences in bone ingrowth between 2 and 6 weeks, and 2 and 12 weeks post-implantation (p= 
0.002, 0.001). 
3.2.2. Bone Contact (BC) 
The contact area in the Ti (green) and Ti-Ag (red) groups were shown in 3D (Fig. 3a-3f). 
An increase in bone contact length was observed as the healing period increased (from 2 – 12 
weeks post-implantation) in both groups. The BC of the Ti (56 ± 10%) and the Ti-Ag group (44 
± 13%) at 6 weeks’ post-implantation was significantly higher than at 2 weeks post-implantation 
(20 ± 6% and 14 ± 5%) (p < 0.05). After 12 weeks implantation, up to 82% of the implant 
surface was colonized by newly formed bone. Significant differences in BC were not observed 
between the titanium and silver coated groups. The quantitative measurements of the BC for both 
groups are summarized in Table 1 and Fig. 3g. 
 Table 1: Bone ingrowth (BI) and bone contact (BC) measured from μCT and histology 
Time 
(weeks) Ti Ti-Ag 
  µCT histology µCT histology 
 BI (%) BC (%) BI (%)  BI (%) BC (%) BI (%)  
2 35±10 20±6 31±9  31±5 14±5 29±8  
6 66±6 56±10 42±7  58±7 44±13 59±15  
12 76±7 71±11 77±6  74±6 73±9 66±10  
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3.2.3. Bone Morphometric parameters  
We observed an increase in trabecular thickness (Tb.Th) and a decrease in specific 
surface area (SSA) and trabecular separation (Tb.Sep) as the healing period increased in both 
groups (Fig. 4). The thickness of the newly formed bone was different between 2 and 6 weeks, 
and 2 and 12 weeks (p < 0.05). No significant differences in SSA, Tb.Th and Tb.Sep were found 
between the uncoated and silver coated titanium groups. There was a significant difference in 
SSA between 2 and 6 weeks, and 2 and 12 weeks (p < 0.05). In the titanium implant, there were 
significant differences between 2 and 6 weeks (62 ± 8 µm and 102 ± 17 µm, p < 0.05), 2 and 12 
weeks (62 ± 8 µm and 122 ± 28 µm, p < 0.05) for Tb.Th. In the silver coated titanium implant, 
the difference in Tb.Th was only observed between 2 (62 ± 24 µm) and 12 weeks (129 ± 25 µm). 
Table 2 Bone morphometric parameters measured from X-ray μCT; specific surface area (SSA); 
trabecular thickness (Tb.Th); trabecular separation (Tb.Sep) 
Time 
(weeks) Ti Ti-Ag 
  
SSA 
(µm-1‰) 
Tb.Th 
(µm) 
Tb.Sep 
(µm) 
SSA 
(µm-1‰) 
Tb.Th 
(µm) 
Tb.Sep 
(µm) 
2 65±6 62±8 139±21 58±7 62±24 163±37 
6 23±2 102±17 109±20 29±2 92±9 121±44 
12 21±3 122±28  108±16 19±3 129±25  120±30 
 
3.3 Quality of newly formed bone using histology and histomorphometry 
In the 2 week samples from the Ti and Ti-Ag groups newly formed bone is seen on both 
the periphery of the defect as well as the surface of implant, where trabecula tended to be smaller 
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in diameter and composed of woven bone (Fig. 5a, 5b). At 6 weeks’ post-implantation, lamellar 
bone is more conspicuous (Fig. 5c, 5d). By 12 weeks, the gap between the implant and defect 
further decreased and lamellar bone predominated (Fig. 5e, 5f).  
The histomorphometrical assessment of BI in the Ti and Ti-Ag group is summarized in 
Fig. 5g and Table 1. In both group, BI was increased significantly between 2 and 12 weeks post 
implantation. 
3.4 Elemental mapping of newly formed bone using NanoSIMS  
NanoSIMS analysis of the samples revealed local element distributions at the bone-
implant interface at 2 weeks post-implantation in both the Ti (Fig. 6a-6e) and Ti-Ag groups (Fig. 
6f-6j). Brighter regions of the images indicate higher counts for that elemental signal. Strong 
40Ca16O-, 31P12C- and 32S- signals were observed in the bone tissue, 48Ti16O- signals were highest 
from the titanium implant and 12C- was observed in certain areas at the bone-implant interface 
and presumably originates from organic fragments in the bone as well as the resin. 
The heterogeneous distribution of 40Ca16O- and 31P12C- (Fig. 6c, 6d; 6h, 6i) observed at 2 
weeks’ post-implantation over the trabecular network, represents a different degree of maturity 
of the newly formed bone. Bone growth in direct contact along the entire surface of the implant 
(contact osteogenesis) was observed in both groups, revealing osseointegration at early time 
points (Fig. 6c, 6h). 
The NanoSIMS elemental maps of 48Ti16O-, 40Ca16O-, 32S- and 107Ag- signals are given in 
Fig.7. The maps demonstrate the distribution of Ti (Fig. 7 i), Ca (Fig. 7 ii), S (Fig. 7 iii), Ag (Fig. 
7iv), while the merged images (Fig. 7 v) of Ti, Ca and Ag at the implant interface for 2 week Ti 
and 2, 6 and 12 weeks Ti-Ag show the interactions. As before, Ca and S intensities are highest at 
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the bone tissue. Silver was detected in the Ti-Ag samples at all time points (Fig. 7b-d iv). The 
merged images (Fig. 7 v) reveal that silver is slowly released from the implant surface, as 
expected, but interestingly some becomes confined within the newly formed osseous tissue. 
Furthermore, co-localization of silver and sulfur was observed, where, the silver signal indicated 
by red arrows in Fig. 7b-d iv was highest in regions with the high intensity sulfur signal (yellow 
arrows in Fig. 7b-d iii). Additionally, 2 weeks post-implantation, silver in the osseous tissue was 
observed both at the surface of the implant as well as in the trabecula away from the implant. But 
at 6 and 12 weeks silver was found only at the bone attached to the surface of the implant 
(yellow arrow head in Fig. 7d iii, red arrow head in Fig. 7d iv).  
3.5 Correlative imaging using µCT, histology and NanoSIMS 
Correlative multimodal imaging was used to quantify bone tissue within the whole defect 
site, to identify different tissues present in the bone-tissue interface and to visualise their 
elemental makeup. 
At 2 weeks post-implantation, the trabecula structure of the newly formed bone is clearly 
observed in µCT image (Fig. 8a). The histology image (Fig. 8b) shows both the woven bone 
(green/dark green) and fibrous tissue (orange). The inset of histology (Fig. 8b) shows a high 
magnification image of a 50 µm2 region and the corresponding NanoSIMS images of this region 
are shown in Fig. 8c-8g, revealing the Ti, Ca, S and Ag maps within the implant and the newly 
formed tissue. Calcium and sulfur are observed in the newly formed bone, co-localized with 
silver content (107Ag-) both near and distance from the implants.  
At 12 weeks post-implantation, the void space around the porous implant is filled by 
newly formed bone, with significantly increased thickness revealed by the µCT image (Fig. 8h). 
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A region of less attenuating tissue was observed at the bone-implant interface (white arrow 
head), which when correlated to the magnified histology image (Fig. 8i) reveals the fibrous tissue 
is still present at the interface. The co localisation of silver and sulfur in NanoSIMS images is 
only observed at the region near the bone-implant interface (Fig. 8c-8g). 
3.6 TEM and SAED 
TEM images and SAED patterns were collected from the bone implant interface region. Fig. 9a 
shows a low magnification image of a region of silver coated titanium scaffold with tissue 
attached to the surface of the implant. Dotted purple line delineates the interface between 
titanium implant and tissue. Inset of Fig. 9a shows histological image of an electron transparent 
tissue region near the silver coated implants. Both bone (green) and fibrous (orange) tissues were 
identified in close proximity to each other adjacent to the implant surface. TEM micrographs 
from the bone region (white box, inset in Fig. 9a) shows the distinctive ~10 nm width fibrillar 
structures (yellow arrows, Fig. 9b&c) with particles (red arrows, Fig. 9b&c) within these areas. 
Electron diffraction pattern (Fig. 9d) from the area bounded by the circle reveals the crystalline 
nature of the sample. 
4. DISCUSSION 
Prosthetic joint infection (PJI) remains a serious complication after orthopaedic surgery, 
which has led to a number of approaches being developed to modify bacterial adhesion and 
growth on the surfaces of implanted devices. AgNPs are effective in preventing bacterial 
adhesion, biofilm formation and subsequent PJI 14, 16, 20. An investigation by Liu et al. [63] into in 
vitro dissolution of AgNPS in biological medium showed a fast silver release profile up to 12 
hours of incubation, this is the most critical period for the development of PJI (from the time of 
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surgery). However, AgNPs are also known to be cytotoxic in vitro 27, 29, 31, 33 and at high 
concentrations have neurotoxic effects in vivo 52. A previous study 20 on AgNPs coated titanium 
implants showed reduced bacterial (Staphylococcus epidermidis) recovery and biofilm formation 
in vitro. It also showed qualitatively, in vivo bone formation and neovascularisation within the 
pores of the implants. Although several studies have reported the use of silver coated devices for 
orthopaedic applications, the uptake/distribution of silver in tissue upon release from an implant, 
and its impact on new bone formation is poorly studied. As nano scale silver is readily ionized 
and bioavailable, there is a need to understand the uptake by local osteogenic cells and 
potentially harmful effects of silver on bone formation. The present study quantifies the impact 
of AgNPs coating on bone formation, in addition to determining the nanoscale distribution of 
silver within tissues adjacent to the AM implant. 
AgNPs, via the tissue fluid mediated release of metallic silver particles or Ag+ ions 23, 29, 
are known to be involved in the generation of reactive oxygen species 31, apoptosis 28 as well as 
replacing ions that are essential for cellular function (e.g. Ca2+, Mg2+) 33. In the present study, we 
describe a selective laser melted porous Ti scaffold on which a uniform and metallic 
nanoparticulate Ag coating was deposited by atomic layer deposition (ALD) 17. Ultrastructural 
examination of the coating revealed discrete and narrow size distributions (49 ± 3 nm) with no 
discernible particle aggregation (Fig. 1c & d). Growth of ultra-thin Ag films (nominal thickness 
13 nm, if it were uniform rather than particulate islands) allows near atomic scale control over 
the particle size as well as the total amount of silver in the coating. The impact of AgNPs on 
biological behavior is both size 27, 53 and dose-dependent 29-31; these results coupled with the 
complex 3D geometries required for a range of orthopaedic implants, necessitates an exacting 
atomic scale control of the silver deposition that can be readily achieved with the ALD process. 
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Implants and the extent of osteogenesis  
Here, we show by multi-modal correlative imaging techniques and quantitative 
histological studies that at the 2 week time-point an equivalent extent of bone ingrowth into the 
implanted Ti and Ti-Ag scaffolds. Specifically, after 2 weeks, bone ingrowth was observed both 
within the surface of the scaffold as well as the marrow cavity (MC) (Fig. 2a & b). Normal bone 
healing is largely mediated by osteogenic cells (principally osteoblasts and osteoclasts) in 
addition to mesenchymal stem cells provided by the adjacent periosteum and marrow cavity 54. In 
the 6 and 12 week samples, less newly formed bone was detected within the marrow cavity (Fig. 
2c-5f), most-likely mediated by osteoclastic resorption on the inner surface of the regenerated 
cortical bone 55. 
µCT and histology measurements reveal a time-dependent increase in bone formation 
without/with silver coating, which is associated with a significant decrease in SSA and marked 
thickening of trabeculae between the 2 and 6 week samples (Fig. 2b & c; Fig. 4a). Trabecular 
thickening and areas of contiguous ingrowth within either Ti or Ti-Ag scaffolds is conspicuous 
and 2D µCT images reveal pixel intensities that are consistent with adjacent cortical bone from 
12 week samples (Fig. 2f & g; 3e & f). While correlative imaging techniques employing µCT 
and histology to quantify bone ingrowth in AM open-porous titanium implant 50 are useful for 
confirmation of tissue morphology at the micron scale, these techniques have neither the 
resolution nor sensitivity to investigate nanoscale osseointegration and uptake of metallic ions by 
regenerating bone. To address this issue, correlative multimodal imaging was further augmented 
using NanoSIMS and TEM to investigate elemental mapping of the bone-implant interface 
across multiple length scales. Medium resolution (~10 µm) µCT imaging allowed non-
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destructive 3D quantification quantity of regenerated bone within the porous implants. The 
higher resolution (~3 µm) of histological images permits reliable distinguishing of host and 
regenerated bone, in addition to other types of connective tissue. The high lateral spatial 
resolution (~195 nm) afforded by NanoSIMS allowed mapping with high elemental sensitivity, 
and resolution of thin trabecular bone (~1 micron thick) in the vicinity of implants (Fig. 6a, 7b, 
8g). 
Bone growth occurs within the pores of the scaffold via thin trabeculae (Fig. 2b & c) as 
well as directly on the surfaces of Ti and silver coated Ti implants (Fig. 6b & g). These two types 
of bone growth are termed distance (from defect to implant surface) and contact (from implant 
surface to defect) osteogenesis 56, respectively, and lead to bone formation in opposite directions 
and faster osseointegration as evidenced during the 2 - 12 week time points we examined (Fig. 
2b–h). The extent of bone growth along titanium surfaces (measured via bone contact 
percentage; Fig. 3g) is not significantly different between the Ti and Ti-Ag groups, indicating 
that coating of Ti surfaces with AgNPs does not impact osteoconduction within open-porous 
titanium implants.  
Eriksson et al. 57 employed Time-of-Flight SIMS (TOF-SIMS), finding that after 4 weeks 
of implantation in rat tibiae, hydroxyapatite fragments were present at the bone-implant 
interface. In our study, strong signals from 40Ca16O- and 31P12C- were observed at 2 weeks post-
implantation, providing further confirmation of contact osteogenesis on the surface of Ti 
implants coated with AgNPs. 
Silver nanoparticle sulfidation in osseous tissue 
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NanoSIMS results indicate that by 2 weeks, silver from the implant surface is released 
and that local dissemination results in uptake by adjacent osseous tissue (Fig. 7b iv & Fig. 8f). 
Macrophages, the primary phagocytic cell, arrive after 24-72 hours at the site of bone injury and 
are capable of rapidly solubilizing metallic silver extracellularly and then accumulating silver-
sulfur nanocrystals within minutes in lysosome-like structures in vitro 33. A similar process has 
been observed following ingestion of silver coated nanowires by human type 1 alveolar epithelial 
cells suggesting that complexing of silver-sulfur as a possible detoxification mechanism for 
short-term accumulation of free Ag+ 34. A recent study demonstrated that the formation of silver 
sulfide nanocrystals, mediated through strongly adsorbed protein coronas on silver nanoparticles, 
leads to reduced toxicity 35. Since the silver we detected in this study was associated with sulfur, 
it is likely that a similar pathway of detoxification occurs in regenerated bone tissue adjacent to 
the implant surface. This mechanism is consistent with our data showing co-localization of silver 
with sulfur (Fig. 7b v) and our TEM and SAED results showing its biotransformation to silver 
sulfide nanoparticles (Fig. 9b&9c and SAED Fig. 9d) over large sections of bone tissue. The 
combined NanoSIMS and TEM/SAED results provide strong evidence of the mechanism by 
which AgNPs detoxification occurs within regenerating bone. The association of silver sulfide 
only within the osseous tissue could be explained by the abundance of sulfur containing proteins 
(i.e. albumin) 58 and/or sulfur compounds (i.e. H2S) generated during tissue formation 34, 59-61. 
Since silver sulfide is less soluble than silver ions, the effective antimicrobial activity of 
the silver-coated implants will be influenced by the biotransformation process. However, further 
study is required to investigate the efficacy, mode and mechanism of antimicrobial action. 
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The measured SAED pattern (Fig. 9d, dashed red lines) closely matches the theoretical 
nano-crystalline Ag2S pattern 64. However, some elemental silver was also indexed, and 
unindexed lines suggest the presence of other crystalline species such as hydroxy apatite. In 
addition to this, artefacts introduced during sample preparation (e.g. material sputtered from 
other regions) will also complicate the analysis. Distinctive ~10 nm width fibrillar structures 
(yellow arrowheads, Fig. 9b&c) are also visible, which we hypothesize to be collagen type I, as it 
is observed in the newly regenerated bone. 
In vitro, the uptake of silver is considered harmful due to the internalized AgNPs being 
released as silver ions 65, which could generate reactive oxygen species (ROS) and cause cell 
death 29. Of significance, is that AgNPs are actively endocytosed by numerous human cell types 
such as mesenchymal stem cells (MSC) 31, alveolar epithelial type I cells 34, HaCaT keratinocytes 
25 and peripheral blood mononuclear cells (PBMC) 26 consistent with the hypothesis that the 
endolysomomal compartment is the route for detoxification of silver in vitro. Additionally, it is 
well described that the effects of AgNPs are dependent on both their size and cell type being 
investigated in vitro: for example, low concentrations of smaller size particles (around 50nm) 
(similar to the particle size observed on the surface of our ALD coated Ti-implants) are relatively 
benign in L929 fibroblasts 28, hMSC 26, 31 , human PBMC 26 and HaCaT keratinocytes 25. 
However, at high concentrations, small size AgNPs are toxic as demonstrated in 2 human 
osteosarcoma cell lines 30, mouse primary osteoblast and osteoclasts 27 and hMSC 29. 
In vivo studies examining administration via various routes (inhalation, intravenous and 
intraperitoneal) have also highlighted the importance of dose and AgNP size to their toxicity. 
Inhalation of lower doses of AgNPs results in no measureable genotoxicity in bone marrow 66. 
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High doses of orally administered AgNPs result in accumulation in the kidneys as well as liver 
damage 67, in addition to quantifiable bone marrow cell genotoxicity 68. Similarly, intravenous or 
intraperitoneal delivery of a high dose of AgNP’s results in an increased frequency of 
polychromatic erythrocytes in bone marrow 69, functional suppression of the immune system 70 or 
a combined hepatotoxicity and genotoxicity 71. When AgNP’s are dispersed within DL-lactic-co-
glycolic acid 72, incorporated into nanotubes 73-74 or immobilized on Ti 75 prior to implantation 
into bone, the scaffolds are osteoconductive, well integrated show antimicrobial activity and no 
evidence of toxicity. Similar to these aforementioned studies, the AgNP particle size we used in 
our in vivo analysis was both small (~43 nm average) and restricted to the area of regenerating 
bone adjacent to the implant, resulting in excellent osseointegration with no signs of toxicity.  
5. CONCLUSIONS 
Our in vivo experiments enabled the assessment of bone tissue regeneration within a 
uninfected rat tibia defect in response to an antimicrobial silver nanoparticle surface coating.  
The silver nanoparticle-coated porous titanium implants showed comparable bone formation and 
osseointegration to that of the uncoated implants following 2 - 12 weeks of implantation.  
Correlative imaging with nanoSIMS, histomorphometry and 3D X-ray micro-computed 
tomography, was used to analyze silver content in tibiae implanted with these scaffolds. The 
results demonstrated that silver accumulation primarily occurs within the osseous tissue 
immediately adjacent to the surface and was co-localized to sulfur. Transmission electron 
microscopy and selected area electron diffraction patterns reveal the sulfidation of silver, 
forming less toxic Ag2S nanoparticles within the newly formed bone.  
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FIGURE LEGENDS 
 
Fig. 1. (a) Macroscopic SEM-SE image of the additively manufactured porous titanium scaffold. 
High-resolution SEM images of (b) titanium scaffolds and (c) silver coated titanium scaffolds. 
(d) Size distribution histogram of silver particles (125 °C for 500 ALD cycles).  
 
Fig. 2. (a) X-ray micro CT (µCT) images of bone formation within the region of interest (ROI). 
Bone ingrowth was quantified at (b,c) 2, (d,e) 6 and (f,g) 12 weeks post-operation. Arrows 
indicate the newly regenerated bone in the uncoated (green) and silver coated group (red). (h) 
The amount of bone ingrowth, expressed as the percentage bone volume within ROI as measured 
by µCT. Statistical significance (*) was considered where p < 0.05. Scale bars 500 μm.  
 
Fig. 3. µCT images of bone to titanium scaffold contact with and without silver coating at (a, b) 
2, (c, d) 6 and (e, f) 12 weeks post-implantation. (g) Bone contact, expressed as the percentage of 
bone implant contact within the region of interest (ROI) as measured by µCT. Statistical 
significance (*) was considered where p < 0.05. Scale bars 500 μm.  
 
Fig. 4. Bone morphometric parameters. (a) Specific surface area (SSA), (b) trabecular bone 
thickness (Tb.Th) and (c) trabecular bone separation (Tb.Sep) as measured by µCT. 
Representative µCT images are inset into (a).  Statistical significance (*) was considered where p 
< 0.05. Scale bars 200 μm.  
 
Fig. 5. Representative histology images of haematoxylin and multiple stained bone-titanium 
implant sections at (a, b) 2, (c, d) 6 and (e, f) 12 weeks post-implantation. (g) Bone ingrowth in 
Ti and Ti-Ag groups (n = 3) is measured from histomorphometry. Statistical significant was 
considered where p < 0.05. Scale bars 200 μm.  
 
Fig. 6. NanoSIMS elemental images of bone-implant interface in (a-e) titanium and (f-j) silver 
coated titanium implants after 2 weeks implantation. The NanoSIMS images (50x50 μm2) were 
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acquired using CAMECA NanoSIMS 50L instrument equipped with Cs+ primary ion beam. 
Images reveal the co-localization of sulfur (measured as 32S-) and Ca/P (measured as 40Ca16O-  and 
31P12C-, respectively). The arrows highlight the direct contact between the newly formed osseous 
tissue (measured as 40Ca16O-  and 31P12C-, respectively) and implants (measured as 48Ti16O-) in 
both groups. Scale bars 10 μm. 
 
Fig. 7. NanoSIMS elemental images of bone-implant interface after (a-b) 2, (c) 6 and (d) 12 
weeks implantation. The NanoSIMS images of 48Ti16O- (i), 40Ca16O- (ii), 107Ag- (iii), 32S-  (iv) and 
merged (v) (superposition of 48Ti16O-, 40Ca16O- and 107Ag- ) were used to determine the uptake of 
silver. A comparison of images in Ti and Ti-Ag group at 2 weeks post-implantation (aii, aiv, bii, 
biv) reveals the silver (measured as107Ag-) is taken up into the osseous tissue (measured as 
40Ca16O-). At 2 weeks post-implantation, the NanoSIMS images of 107Ag- (red arrows) and 32S- 
(yellow arrows) reveal the co-localization of silver and sulfur in the newly formed bone. At 6 
and 12 weeks post-implantation, co-localization of 107Ag- (red arrow head) and 32S- (yellow arrow 
head) is only observed at the region near the periphery of implant. Scale bars 10 μm.  
 
Fig. 8. (a-n) Correlative imaging of µCT, Goldners trichrome stained histology and NanoSIMS 
show different tissue types and the uptake of silver. At 2 weeks post-implantation, the newly 
formed bone is observed in both (a) µCT and (b) histology image. Correlative (b) histology and 
(c-g) NanoSIMS images shows the woven bone and fibrous tissue at the bone-implant interface. 
The co-localization of silver and sulfur occurs in the newly formed woven bone. At 12 weeks 
post-implantation, the void space of the porous implant is filled with more matured bone, as 
shown in (h) µCT image. Correlative (i) histology and NanoSIMS images (j-n) show the lamellar 
bone and fibrous tissue at the bone-implant interface.  
 
Fig. 9. (a) TEM image of a region containing a silver coated titanium scaffold and surrounding 
tissue at two weeks post implantation. The dotted line delineates the interface between titanium 
implant and regenerated tissue. Inset (from boxed area) is a histological image of an electron 
transparent tissue region adjacent to the implant that shows mineralized bone (stained green) 
next to fibrous connective tissue (stained orange). Higher magnification TEM images (b) & (c) 
from the area of bone identified in the inset reveals distinctive ~10 nm width fibrillar structures 
(yellow arrowheads) and electron dense particles (red arrowheads). The association of the 
fibrillary structures with the electron dense particles is conspicuous (c). A selected area electron 
diffraction (SAED) pattern of the encircled area in (b) was performed using a selected area 
aperture size of ~400 nm. The concentric rings (d) imply the presence of a crystalline 
nanoparticulate phase. The SAED pattern observed matches the standard silver sulfide pattern 
(dotted arc line in red) strongly supporting the hypothesis that the particles in the TEM images 
are silver sulfide. Scale bars = 10 µm in (a) and inset; (b) = 100 nm, (c) = 20 nm and (d) = 5 nm-1 
(in reciprocal space). 
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Fig. 1. (a) Macroscopic SEM-SE image of the additively
manufactured porous titanium scaffold. High-resolution
SEM images of (b) titanium scaffolds and (c) silver
coated titanium scaffolds. (d) Size distribution histogram
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Fig. 2. (a) X-ray micro CT (µCT) images of bone
formation within the region of interest (ROI). Bone
ingrowth was quantified at (b,c) 2, (d,e) 6 and (f,g) 12
weeks post-operation. Arrows indicate the newly
regenerated bone in the uncoated (green) and silver
coated group (red). (h) The amount of bone ingrowth,
expressed as the percentage bone volume within ROI as
measured by µCT. Statistical significance (*) was
considered where p < 0.05. Scale bars 500 µm.
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Fig. 3. µCT images of bone to titanium scaffold contact
with and without silver coating at (a, b) 2, (c, d) 6 and (e,
f) 12 weeks post-implantation. (g) Bone contact,
expressed as the percentage of bone implant contact
within the region of interest (ROI) as measured by µCT.
Statistical significance (*) was considered where p <
0.05. Scale bars 500 µm.
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Fig. 4. Bone morphometric parameters. (a) Specific
surface area (SSA), (b) trabecular bone thickness (Tb.Th)
and (c) trabecular bone separation (Tb.Sep) as measured
by µCT. Representative µCT images are inset into (a).
Statistical significance (*) was considered where p <
0.05. Scale bars 200 µm.
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Fig. 5. Representative histology images of haematoxylin
and multiple stained bone-titanium implant sections at (a,
b) 2, (c, d) 6 and (e, f) 12 weeks post-implantation. (g)
Bone ingrowth in Ti and Ti-Ag groups (n = 3) is
measured from histomorphometry. Statistical significant
was considered where p < 0.05. Scale bars 200 µm.
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Fig. 6. NanoSIMS elemental images of bone-implant interface in (a-e) titanium and (f-j) silver coated titanium
implants after 2 weeks implantation. The NanoSIMS images (50x50 µm2) were acquired using CAMECA
NanoSIMS 50L instrument equipped with Cs+ primary ion beam. Images reveal the colocalisation of sulfur
(measured as 32S-) and Ca/P (measured as 40Ca16O- and 31P12C-, respectively). The arrows highlight the direct
contact between the newly formed osseous tissue (measured as 40Ca16O- and 31P12C-, respectively) and implants
(measured as 48Ti16O-) in both groups. Scale bars 10 µm.
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Fig. 7. NanoSIMS elemental images of bone-implant interface after (a-b) 2, (c) 6 and (d) 12 weeks implantation.
The NanoSIMS images of 48Ti16O- (i), 40Ca16O- (ii), 107Ag- (iii), 32S- (iv) and merged (v) (superposition of 48Ti16O-,
40Ca16O- and 107Ag- ) were used to determine the uptake of silver. A comparison of images in Ti and Ti-Ag group at
2 weeks post-implantation (aii, aiv, bii, biv) reveals the silver (measured as107Ag-) is taken up into the osseous
tissue (measured as 40Ca16O-). At 2 and 6 weeks post-implantation, the NanoSIMS images of 107Ag- (red arrows)
and 32S- (yellow arrows) reveal the colocalisation of silver and sulfur in the newly formed bone. At 12 weeks post-
implantation, colocolisation of 107Ag- (red arrow head) and 32S- (yellow arrow head) is only observed at the region
near the periphery of implant. Scale bars 10 µm.
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Fig. 8. (a-n) Correlative imaging of µCT, goldners trichrome stained histology and NanoSIMS show different
tissue types and the uptake of silver. At 2 weeks post-implantation, the newly formed bone is observed in both (a)
µCT and (b) histology image. Correlative (b) histology and (c-g) NanoSIMS images shows the woven bone and
fibrous tissue at the bone-implant interface. The colocalisation of silver and sulfur occurs in the newly formed
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bone, as shown in (h) µCT image. Correlative (i) histology and NanoSIMS images (j-n) show bone and fibrous
tissue at the bone-implant interface.
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Fig. 9. (a) TEM image of a region containing a silver coated titanium scaffold and surrounding tissue at two weeks
post implantation. The dotted line delineates the interface between titanium implant and regenerated tissue. Inset
(from boxed area) is a histological image of an electron transparent tissue region adjacent to the implant that
shows mineralised bone (stained green) next to fibrous connective tissue (stained orange). Higher magnification
TEM images (b) & (c) from the area of bone identified in the inset (white box) reveals distinctive ~10 nm width
fibrillar structures (yellow arrowheads) and electron dense particles (red arrowheads). The association of the
fibrillary structures with the electron dense particles is conspicuous (c). A selected area electron diffraction
(SAED) pattern of the encircled area in (b) was performed using a selected area aperture size of ~400 nm. The
concentric rings (d) imply the presence of a crystalline nanoparticulate phase. The SAED pattern observed
matches closely the standard silver sulfide pattern (dotted arc line in red) strongly supporting the hypothesis that
the particles in the TEM images are silver sulfide. Scale bars = 10 µm in (a) and inset; (b) = 100 nm, (c) = 20 nm
and (d) = 5 nm-1 (in reciprocal space).
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